Drug Shortage Report for APO-SALBUTAMOL HFA

Last updated on 2022-06-17 History
Report ID 156387
Drug Identification Number 02245669
Brand name APO-SALBUTAMOL HFA
Common or Proper name SALBUTAMOL HFA
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SALBUTAMOL
Strength(s) 100MCG
Dosage form(s) METERED-DOSE AEROSOL
Route of administration INHALATION INHALATION
Packaging size 200MD
ATC code R03AC
ATC description ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-04-15
Actual start date 2022-04-12
Estimated end date 2022-06-17
Actual end date 2022-06-16
Shortage status Resolved
Updated date 2022-06-17
Company comments There will be limited inventory releases before full recovery in June
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2022-06-17 French Compare
v16 2022-06-17 English Compare
v15 2022-06-17 English Compare
v14 2022-04-29 French Compare
v13 2022-04-29 English Compare
v12 2022-04-21 French Compare
v11 2022-04-21 English Compare
v10 2022-04-14 French Compare
v9 2022-04-14 English Compare
v8 2022-04-13 English Compare
v7 2022-04-12 French Compare
v6 2022-04-12 French Compare
v5 2022-04-12 English Compare
v4 2022-04-01 French Compare
v3 2022-04-01 English Compare
v2 2022-03-09 French Compare
v1 2022-03-09 English Compare

Showing 1 to 17 of 17